SCHEMBL5887003

SCHEMBL5887003

CC(=O)N1CCN(c2nc(C)c3ccc(=O)n(-c4ccc(C(N)=O)cc4)c3n2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.38
GFER P55789 1/20 0.38
GBA1 P04062 1/20 0.38
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
SYK P43405 2/20 0.36
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND2 P30279 1/20 0.35
CCND3 P30281 1/20 0.35
CHEK1 O14757 1/20 0.35
PIK3CD O00329 1/20 0.35
MTOR P42345 1/20 0.34
NCF1 P14598 2/20 0.34
C1S P09871 2/20 0.34
ACVR1 Q04771 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886817 0.92 MGLL (0.36) GBA1ALDH1A1HPGDCYP2C19CHEK1
SCHEMBL5887525 0.90 NPC1 (0.46) MAPTALDH1A1CHEK1ACVR1MEN1
SCHEMBL5887184 0.90 CHEK1 (0.46) ALDH1A1CYP2C9HPGDCYP2C19CDK4
SCHEMBL5887307 0.88 ALDH1A1 (0.44) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL5886744 0.88 MGLL (0.46) GBA1MAPTALDH1A1C1SMGLL
SCHEMBL5886830 0.88 ALDH1A1 (0.42) MAPTALDH1A1CYP2C9HPGDCYP2C19
SCHEMBL5887194 0.88 ESR1 (0.43) MAPTALDH1A1HPGDCDK4CCND1
SCHEMBL5886806 0.87 ALDH1A1 (0.36) MAPTALDH1A1HPGDCYP2C19CDK4
SCHEMBL5887520 0.87 MEN1 (0.44) MAPTALDH1A1HPGDCHEK1MEN1
SCHEMBL5886902 0.85 GBA1 (0.46) GFERGBA1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP CASP6 1306/4885GFER 4505/4885GBA1 4528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.